Released on = November 3, 2006, 12:41 pm

Press Release Author = GTCbio

Industry = Healthcare

Press Release Summary = An upcoming conference on Epigenetic Cancer Therapy will
bring scientists together to discuss research that targets epigenetic processes for
cancer therapy. Speakers from leading research organizations including Johns
Hopkins University, Harvard Medical School, The Ohio State University, The German
Cancer Center, the National Cancer Institute and M.D. Anderson Cancer Center will be
among the distinguished panel of speakers at this event.

Press Release Body = MONROVIA, CA - The World Health Organization estimates that by
2020 cancer rates will double affecting 15 million people worldwide. However, a new
report from the nation\'s leading cancer organizations found that death rates in
America decreased for 11 of the 15 most common cancers in men and for 10 of the 15
most common cancers in women. The report names more effective treatments as one of
the factors for the decline.

Continued success in lowering the cancer mortality rate will depend on maintaining
and enhancing these efforts. An upcoming conference on Epigenetic Cancer Therapy
will bring scientists together to discuss research that targets epigenetic processes
for cancer therapy. Speakers from leading research organizations including Johns
Hopkins University, Harvard Medical School, The Ohio State University, The German
Cancer Center, the National Cancer Institute and M.D. Anderson Cancer Center will be
among the distinguished panel of speakers at this event.

Some of the topics to be examined are DNA Methylation and Cancer, Preclinical and
Clinical Developments of DNA Methyl-transferase Inhibitors, DNA Methylation as a
Diagnostic Tool in Cancer and Chromatin Modification Remodeling.

Epigenetic Cancer Therapy is a part of the 2nd Modern Drug Discovery & Development
Summit (M3D 2006). The Summit will take place December 4-6, 2006 at the
Pennsylvania Convention Center. Over 250 speakers will participate in 11 concurrent
conferences. For more information, visit www.gtcbio.com


Web Site = http://www.gtcbio.com

Contact Details = ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.
For more information contact Christy Bowman at GTCbio. Phone: (626) 256-6405 x101,
Fax: (626) 256-6460, Email: Christy.bowman@gtcbio.com